Centene Corp.

Centene is an insurance holding company. The company's Managed Care segment provides health plan coverage to individuals through government subsidized programs. The company also provides a variety of individual, small group, and large group commercial healthcare products, both to employers and directly to members in the Managed Care segment. The company's Specialty Services segment consists of the company's specialty companies prviding healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations, as well as to its own subsidiaries. The Specialty Service segment also includes the Government Contracts business.
  • TickerCNC
  • ISINUS15135B1017
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States
CNC CENTENE CORP. (Health Care)

Moody's rates Centene's senior notes Ba1;outlook stable

$1.8 billion of new debt rated New York , June 24, 2021 – Moody's Investors Service has assigned a Ba1 senior unsecured debt rating to Centene Corporation's (Centene; NYSE: CNC) planned issuance of approximately $1.8 billion of senior unsecured debt, due June 2028. Net proceeds from the offer...

CNC CENTENE CORP. (Health Care)

Centene Corporation: Sizeable reserve charge for Medicaid pricing is c...

Centene’s reserve charge is credit negative but removes uncertainty.

CNC CENTENE CORP. (Health Care)

Centene Corp: 1 director

A director at Centene Corp sold 25,000 shares at 71.170USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

Valens Research
  • Valens Research
CNC CENTENE CORP. (Health Care)

CNC - Embedded Expectations Analysis - 2021 06 09

Centene Corporation (CNC:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) earnings, with a 12.6x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, but management is confident about their revenue growth drivers, Medicare Stars margin expansion, and macro tailwinds Specifically, management is confident the new business win in Oklahoma will drive revenue growth, that they increased their estimate of the state rate and risk-sharing mechanism revenue impact to $550 million, and that the business will experience macro tailwinds...

Valens Research
  • Valens Research
CNC CENTENE CORP. (Health Care)

CNC - Valens Credit Report - 2021 05 17

Credit markets are accurately stating CNC's credit risk with a YTW of 1.928% and CDS of 125bps relative to an Intrinsic YTW of 1.658% and Intrinsic CDS of 89bps. Meanwhile, Moody's is materially overstating the firm's fundamental credit risk, with its non-investment grade Ba1 credit rating five notches lower than Valens' IG3 (A2) credit rating Incentives Dictate Behavior™ analysis highlights mostly positive signals for credit holders. Management's compensation framework should drive them to focus heavily on margin expansion and revenue growth, which may lead to Uniform ROA improvement and hig...

CNC CENTENE CORP. (Health Care)

Moody's rates Centene's senior notes Ba1;outlook stable

$1.8 billion of new debt rated New York , June 24, 2021 – Moody's Investors Service has assigned a Ba1 senior unsecured debt rating to Centene Corporation's (Centene; NYSE: CNC) planned issuance of approximately $1.8 billion of senior unsecured debt, due June 2028. Net proceeds from the offer...

CNC CENTENE CORP. (Health Care)

Centene Corporation: Sizeable reserve charge for Medicaid pricing is c...

Centene’s reserve charge is credit negative but removes uncertainty.

CNC CENTENE CORP. (Health Care)

Centene Corp: 1 director

A director at Centene Corp sold 25,000 shares at 71.170USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

Valens Research
  • Valens Research
CNC CENTENE CORP. (Health Care)

CNC - Embedded Expectations Analysis - 2021 06 09

Centene Corporation (CNC:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) earnings, with a 12.6x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, but management is confident about their revenue growth drivers, Medicare Stars margin expansion, and macro tailwinds Specifically, management is confident the new business win in Oklahoma will drive revenue growth, that they increased their estimate of the state rate and risk-sharing mechanism revenue impact to $550 million, and that the business will experience macro tailwinds...

Valens Research
  • Valens Research
CNC CENTENE CORP. (Health Care)

CNC - Valens Credit Report - 2021 05 17

Credit markets are accurately stating CNC's credit risk with a YTW of 1.928% and CDS of 125bps relative to an Intrinsic YTW of 1.658% and Intrinsic CDS of 89bps. Meanwhile, Moody's is materially overstating the firm's fundamental credit risk, with its non-investment grade Ba1 credit rating five notches lower than Valens' IG3 (A2) credit rating Incentives Dictate Behavior™ analysis highlights mostly positive signals for credit holders. Management's compensation framework should drive them to focus heavily on margin expansion and revenue growth, which may lead to Uniform ROA improvement and hig...

CNC CENTENE CORP. (Health Care)

Moody's rates Centene's senior notes Ba1;outlook stable

$1.8 billion of new debt rated New York , June 24, 2021 – Moody's Investors Service has assigned a Ba1 senior unsecured debt rating to Centene Corporation's (Centene; NYSE: CNC) planned issuance of approximately $1.8 billion of senior unsecured debt, due June 2028. Net proceeds from the offer...

CNC CENTENE CORP. (Health Care)

Centene Corporation: Sizeable reserve charge for Medicaid pricing is c...

Centene’s reserve charge is credit negative but removes uncertainty.

CNC CENTENE CORP. (Health Care)

Centene Corp: 1 director

A director at Centene Corp sold 25,000 shares at 71.170USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

Valens Research
  • Valens Research
CNC CENTENE CORP. (Health Care)

CNC - Embedded Expectations Analysis - 2021 06 09

Centene Corporation (CNC:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) earnings, with a 12.6x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, but management is confident about their revenue growth drivers, Medicare Stars margin expansion, and macro tailwinds Specifically, management is confident the new business win in Oklahoma will drive revenue growth, that they increased their estimate of the state rate and risk-sharing mechanism revenue impact to $550 million, and that the business will experience macro tailwinds...

Valens Research
  • Valens Research
CNC CENTENE CORP. (Health Care)

CNC - Valens Credit Report - 2021 05 17

Credit markets are accurately stating CNC's credit risk with a YTW of 1.928% and CDS of 125bps relative to an Intrinsic YTW of 1.658% and Intrinsic CDS of 89bps. Meanwhile, Moody's is materially overstating the firm's fundamental credit risk, with its non-investment grade Ba1 credit rating five notches lower than Valens' IG3 (A2) credit rating Incentives Dictate Behavior™ analysis highlights mostly positive signals for credit holders. Management's compensation framework should drive them to focus heavily on margin expansion and revenue growth, which may lead to Uniform ROA improvement and hig...

CNC CENTENE CORP. (Health Care)

Moody's rates Centene's senior notes Ba1;outlook stable

$1.8 billion of new debt rated New York , June 24, 2021 – Moody's Investors Service has assigned a Ba1 senior unsecured debt rating to Centene Corporation's (Centene; NYSE: CNC) planned issuance of approximately $1.8 billion of senior unsecured debt, due June 2028. Net proceeds from the offer...

CNC CENTENE CORP. (Health Care)

Centene Corporation: Sizeable reserve charge for Medicaid pricing is c...

Centene’s reserve charge is credit negative but removes uncertainty.

CNC CENTENE CORP. (Health Care)

Centene Corp: 1 director

A director at Centene Corp sold 25,000 shares at 71.170USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

Valens Research
  • Valens Research
CNC CENTENE CORP. (Health Care)

CNC - Embedded Expectations Analysis - 2021 06 09

Centene Corporation (CNC:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) earnings, with a 12.6x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, but management is confident about their revenue growth drivers, Medicare Stars margin expansion, and macro tailwinds Specifically, management is confident the new business win in Oklahoma will drive revenue growth, that they increased their estimate of the state rate and risk-sharing mechanism revenue impact to $550 million, and that the business will experience macro tailwinds...

Valens Research
  • Valens Research
CNC CENTENE CORP. (Health Care)

CNC - Valens Credit Report - 2021 05 17

Credit markets are accurately stating CNC's credit risk with a YTW of 1.928% and CDS of 125bps relative to an Intrinsic YTW of 1.658% and Intrinsic CDS of 89bps. Meanwhile, Moody's is materially overstating the firm's fundamental credit risk, with its non-investment grade Ba1 credit rating five notches lower than Valens' IG3 (A2) credit rating Incentives Dictate Behavior™ analysis highlights mostly positive signals for credit holders. Management's compensation framework should drive them to focus heavily on margin expansion and revenue growth, which may lead to Uniform ROA improvement and hig...

CNC CENTENE CORP. (Health Care)

Moody's rates Centene's senior notes Ba1;outlook stable

$1.8 billion of new debt rated New York , June 24, 2021 – Moody's Investors Service has assigned a Ba1 senior unsecured debt rating to Centene Corporation's (Centene; NYSE: CNC) planned issuance of approximately $1.8 billion of senior unsecured debt, due June 2028. Net proceeds from the offer...

CNC CENTENE CORP. (Health Care)

Centene Corporation: Sizeable reserve charge for Medicaid pricing is c...

Centene’s reserve charge is credit negative but removes uncertainty.

CNC CENTENE CORP. (Health Care)

Centene Corp: 1 director

A director at Centene Corp sold 25,000 shares at 71.170USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

Valens Research
  • Valens Research
CNC CENTENE CORP. (Health Care)

CNC - Embedded Expectations Analysis - 2021 06 09

Centene Corporation (CNC:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) earnings, with a 12.6x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, but management is confident about their revenue growth drivers, Medicare Stars margin expansion, and macro tailwinds Specifically, management is confident the new business win in Oklahoma will drive revenue growth, that they increased their estimate of the state rate and risk-sharing mechanism revenue impact to $550 million, and that the business will experience macro tailwinds...

Valens Research
  • Valens Research
CNC CENTENE CORP. (Health Care)

CNC - Valens Credit Report - 2021 05 17

Credit markets are accurately stating CNC's credit risk with a YTW of 1.928% and CDS of 125bps relative to an Intrinsic YTW of 1.658% and Intrinsic CDS of 89bps. Meanwhile, Moody's is materially overstating the firm's fundamental credit risk, with its non-investment grade Ba1 credit rating five notches lower than Valens' IG3 (A2) credit rating Incentives Dictate Behavior™ analysis highlights mostly positive signals for credit holders. Management's compensation framework should drive them to focus heavily on margin expansion and revenue growth, which may lead to Uniform ROA improvement and hig...

CNC CENTENE CORP. (Health Care)

Moody's rates Centene's senior notes Ba1;outlook stable

$1.8 billion of new debt rated New York , June 24, 2021 – Moody's Investors Service has assigned a Ba1 senior unsecured debt rating to Centene Corporation's (Centene; NYSE: CNC) planned issuance of approximately $1.8 billion of senior unsecured debt, due June 2028. Net proceeds from the offer...

CNC CENTENE CORP. (Health Care)

Centene Corporation: Sizeable reserve charge for Medicaid pricing is c...

Centene’s reserve charge is credit negative but removes uncertainty.

CNC CENTENE CORP. (Health Care)

Centene Corp: 1 director

A director at Centene Corp sold 25,000 shares at 71.170USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

Valens Research
  • Valens Research
CNC CENTENE CORP. (Health Care)

CNC - Embedded Expectations Analysis - 2021 06 09

Centene Corporation (CNC:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) earnings, with a 12.6x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, but management is confident about their revenue growth drivers, Medicare Stars margin expansion, and macro tailwinds Specifically, management is confident the new business win in Oklahoma will drive revenue growth, that they increased their estimate of the state rate and risk-sharing mechanism revenue impact to $550 million, and that the business will experience macro tailwinds...

Valens Research
  • Valens Research
CNC CENTENE CORP. (Health Care)

CNC - Valens Credit Report - 2021 05 17

Credit markets are accurately stating CNC's credit risk with a YTW of 1.928% and CDS of 125bps relative to an Intrinsic YTW of 1.658% and Intrinsic CDS of 89bps. Meanwhile, Moody's is materially overstating the firm's fundamental credit risk, with its non-investment grade Ba1 credit rating five notches lower than Valens' IG3 (A2) credit rating Incentives Dictate Behavior™ analysis highlights mostly positive signals for credit holders. Management's compensation framework should drive them to focus heavily on margin expansion and revenue growth, which may lead to Uniform ROA improvement and hig...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch